ArticlePloS one2023

White matter hyperintensities in cholinergic pathways may predict poorer responsiveness to acetylcholinesterase inhibitor treatment for Alzheimer's disease.

Li-Hua Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.